江陰銀行(002807.SZ):獲准發行不超20億元小微企業專項金融債券
格隆匯 7 月 30日丨江陰銀行(002807.SZ)宣佈,公司已收到中國銀保監會江蘇監管局和中國人民銀行關於同意本行發行小微企業專項金融債券的批文。根據《中國銀保監會江蘇監管局關於江蘇江陰農村商業銀行發行小微企業專項金融債券的批覆》(蘇銀保監復﹝2020﹞239號)和《中國人民銀行准予行政許可決定書》(銀許准予決字﹝2020﹞第51號),同意江陰銀行在全國銀行間債券市場公開發行不超過20億元人民幣金融債券,專項用於發放小型微型企業貸款。行政許可有效期為2020年7月25日至2022年7月24日,在有效期內可自主選擇分期發行時間。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.